Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron PharmafiledCriticalRegeneron Pharma
Priority claimed from PCT/US2017/064215external-prioritypatent/WO2018102682A1/fr
Publication of MA45966A1publicationCriticalpatent/MA45966A1/fr
Publication of MA45966B2publicationCriticalpatent/MA45966B2/fr
102000004169proteins and genesHuman genes0.000abstract1
108090000623proteins and genesProteins0.000abstract1
Landscapes
Peptides Or Proteins
(AREA)
Abstract
L'invention concerne des anticorps anti-pd-l1 radiomarqués et leur utilisation dans l'imagerie immuno-tep. L'invention concerne également des procédés de détection de la présence de protéines pd-l1 chez un patient ou dans un échantillon.
MA45966A2016-12-012017-12-01Anticorps anti-pd-l1 radiomarqués pour imagerie immuno-pet
MA45966B2
(fr)